Healthcare -
Biotechnology - NASDAQ - US
$ 1.5547
1.61 %
$ 16.6 M
Market Cap
-1.45
P/E
MRKR - COST OF REVENUE
Cost of Revenue MRKR - Marker Therapeutics, Inc.
10.4 M
LAST VALUE
81.49%
2 YEAR CAGR
-39.07%
5 YEAR CAGR
0.00%
10 YEAR CAGR